Evidence map›Paper›PMID 34539126›Full record

ArticleInternational journal of diabetes in developing countries2022

How the COVID-19 outbreak affected patients with diabetes mellitus?

Pinar Sisman, Irmak Polat, Ensar Aydemir, Remzi Karsi, Ozen Oz Gul, Soner Cander, Canan Ersoy, Erdinc Erturk

Open access · bronzeAbstract read
In one paragraph

Article in International journal of diabetes in developing countries, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. The Experiences of People with Diabetes during COVID-19 Pandemic Lockdown.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Pinar SismanMedicana Hospital, Endocrinology and Metabolism Clinic, Bursa, Turkey.
Irmak PolatIstanbul Faculty of Medicine Department of Psychiatry, Istanbul University, Istanbul, Turkey.
Ensar AydemirMedical School Department of Endocrinology and Metabolism, Uludag University, Bursa, Turkey.
Remzi KarsiSchool of Health Science, KTO Karatay University, Konya, Turkey.
Ozen Oz GulMedical School Department of Endocrinology and Metabolism, Uludag University, Bursa, Turkey.
Soner CanderMedical School Department of Endocrinology and Metabolism, Uludag University, Bursa, Turkey.
Canan ErsoyMedical School Department of Endocrinology and Metabolism, Uludag University, Bursa, Turkey.
Erdinc ErturkMedical School Department of Endocrinology and Metabolism, Uludag University, Bursa, Turkey.
Bursa Uludağ Üni̇versi̇tesi̇ · TRIstanbul University · TRKTO Karatay University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Global COVID-19 outbreak has been such a stressful experience for most of the people. Using a web-based cross-sectional study, we aimed to evaluate the acute stress response, depression, and anxiety in patients with diabetes mellitus (DM) during the COVID-19 pandemic, and to examine the effect of these psychiatric problems on diet habits and glycemic controls of patients. Methods: This web-based survey of COVID-19 was sent to the patients through the Whatsapp platform. All participants reported their demographic data, diabetes-related information, changes in self-monitoring blood glucose measurements, physical parameters, and eating habits after COVID-19, then completed Hospital Anxiety and Depression Scale (HADS) and the Impact of Event Scale, Revised (IES-R) questionnaires which assessed acute stress sypmtoms, anxiety, and depression. Results: Three hundred and four patients with DM [(141 type 1 DM (T1D) and 163 type 2 (T2D)] were included in the study. In our study, female gender, higher BMI and weight, decreased in financial income after outbreak, presence of diabetic complications and comorbid diseases (i.e., retinopathy, neuropathy, diabetic foot, hypertension, dyslipidemia), worsened glycemic levels, increased carbohydrate consumption, and snacking were associated with higher anxiety and depression scores. Depression was higher in patients with T2D and duration of illness was correlated with acute stress level. Conclusions: It is important to be aware of the possibility of acute stress, depression, and anxiety after pandemic in patients with DM whose glycemic control is impaired. Psychological problems should not be ignored beyond physical inactivity and worsening eating habits.

Indexed as

AnxietyCOVID-19DepressionDiabetes mellitusPandemic

Identifiers

PMID34539126
PMCPMC8432957
OpenAlexW3201490534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.